BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 12676890)

  • 1. Risperidone attenuates the discriminative-stimulus effects of d-amphetamine in humans.
    Rush CR; Stoops WW; Hays LR; Glaser PE; Hays LS
    J Pharmacol Exp Ther; 2003 Jul; 306(1):195-204. PubMed ID: 12676890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aripiprazole attenuates the discriminative-stimulus and subject-rated effects of D-amphetamine in humans.
    Lile JA; Stoops WW; Vansickel AR; Glaser PE; Hays LR; Rush CR
    Neuropsychopharmacology; 2005 Nov; 30(11):2103-14. PubMed ID: 15988473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxazepam does not modulate the behavioral effects of d-amphetamine in humans.
    Lile JA; Stoops WW; Wagner FP; Glaser PE; Rush CR
    Pharmacol Biochem Behav; 2005 Oct; 82(2):270-9. PubMed ID: 16182353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discriminative-stimulus, self-reported, performance, and cardiovascular effects of atomoxetine in methylphenidate-trained humans.
    Lile JA; Stoops WW; Durell TM; Glaser PE; Rush CR
    Exp Clin Psychopharmacol; 2006 May; 14(2):136-47. PubMed ID: 16756417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aripiprazole as a potential pharmacotherapy for stimulant dependence: human laboratory studies with d-amphetamine.
    Stoops WW
    Exp Clin Psychopharmacol; 2006 Nov; 14(4):413-21. PubMed ID: 17115868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discriminative stimulus and self-reported effects of methylphenidate, d-amphetamine, and triazolam in methylphenidate-trained humans.
    Stoops WW; Lile JA; Glaser PE; Rush CR
    Exp Clin Psychopharmacol; 2005 Feb; 13(1):56-64. PubMed ID: 15727504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the discriminative stimulus produced by the dopamine antagonist tiapride.
    Cohen C; Sanger DJ; Perrault G
    J Pharmacol Exp Ther; 1997 Nov; 283(2):566-73. PubMed ID: 9353371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discriminative stimulus, subject-rated and cardiovascular effects of cocaine alone and in combination with aripiprazole in humans.
    Lile JA; Stoops WW; Glaser PE; Hays LR; Rush CR
    J Psychopharmacol; 2011 Nov; 25(11):1469-79. PubMed ID: 20952456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discriminative stimulus effects of zolpidem in pentobarbital-trained subjects: II. Comparison with triazolam and caffeine in humans.
    Rush CR; Madakasira S; Goldman NH; Woolverton WL; Rowlett JK
    J Pharmacol Exp Ther; 1997 Jan; 280(1):174-88. PubMed ID: 8996195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of acute and subchronic d-amphetamine on ventral striatal concentrations of neurotensin and neuropeptide Y in rats treated with antipsychotic drugs.
    Gruber SH; Nomikos GG; Mathé AA
    Eur Neuropsychopharmacol; 2006 Dec; 16(8):592-600. PubMed ID: 16524702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of d-amphetamine and caffeine in humans under a cocaine discrimination procedure.
    Oliveto AH; McCance-Katz E; Singha A; Hameedi F; Kosten TR
    Behav Pharmacol; 1998 May; 9(3):207-17. PubMed ID: 9832935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of some drugs of abuse on the discriminative stimulus properties of amphetamine.
    Druhan JP; Fibiger HC; Phillips AG
    Behav Pharmacol; 1991 Nov; 2(4 And 5):391-403. PubMed ID: 11224082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alprazolam attenuates the behavioral effects of d-amphetamine in humans.
    Rush CR; Stoops WW; Wagner FP; Hays LR; Glaser PE
    J Clin Psychopharmacol; 2004 Aug; 24(4):410-20. PubMed ID: 15232333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effects on the discriminative stimulus properties of D-amphetamine by classical and newer antipsychotics do not correlate with antipsychotic activity. Relation to effects on the reward system?
    Arnt J
    Psychopharmacology (Berl); 1996 Mar; 124(1-2):117-25. PubMed ID: 8935806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A low dose of aripiprazole attenuates the subject-rated effects of d-amphetamine.
    Stoops WW; Lile JA; Glaser PE; Rush CR
    Drug Alcohol Depend; 2006 Sep; 84(2):206-9. PubMed ID: 16540264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the stereoisomers of deprenyl for amphetamine-like discriminative stimulus effects in rats.
    Yasar S; Schindler CW; Thorndike EB; Szelenyi I; Goldberg SR
    J Pharmacol Exp Ther; 1993 Apr; 265(1):1-6. PubMed ID: 8473997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Discriminative stimulus properties of D-amphetamine: a neuropharmacological review].
    Inagawa K
    Yakubutsu Seishin Kodo; 1992 Aug; 12(4):151-65. PubMed ID: 1414035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of dopamine and serotonin in the discriminative stimulus effects of lisuride.
    White FJ; Appel JB
    J Pharmacol Exp Ther; 1982 May; 221(2):421-7. PubMed ID: 7077537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risperidone attenuates and reverses hyperthermia induced by 3,4-methylenedioxymethamphetamine (MDMA) in rats.
    Shioda K; Nisijima K; Yoshino T; Kuboshima K; Iwamura T; Yui K; Kato S
    Neurotoxicology; 2008 Nov; 29(6):1030-6. PubMed ID: 18722468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pretreatment with hydromorphone, a mu-opioid agonist, does not alter the acute behavioral and physiological effects of ethanol in humans.
    Rush CR
    Alcohol Clin Exp Res; 2001 Jan; 25(1):9-17. PubMed ID: 11198720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.